NTLA
Price
$11.87
Change
+$0.25 (+2.15%)
Updated
Feb 13 closing price
Capitalization
1.38B
5 days until earnings call
Intraday BUY SELL Signals
TPST
Price
$2.36
Change
+$0.05 (+2.16%)
Updated
Feb 13 closing price
Capitalization
11.58M
Intraday BUY SELL Signals
Interact to see
Advertisement

NTLA vs TPST

Header iconNTLA vs TPST Comparison
Open Charts NTLA vs TPSTBanner chart's image
Intellia Therapeutics
Price$11.87
Change+$0.25 (+2.15%)
Volume$2.63M
Capitalization1.38B
Tempest Therapeutics
Price$2.36
Change+$0.05 (+2.16%)
Volume$30.87K
Capitalization11.58M
NTLA vs TPST Comparison Chart in %
View a ticker or compare two or three
VS
NTLA vs. TPST commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (NTLA: $11.87 vs. TPST: $2.36)
Brand notoriety: NTLA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 53% vs. TPST: 29%
Market capitalization -- NTLA: $1.38B vs. TPST: $11.58M
NTLA [@Biotechnology] is valued at $1.38B. TPST’s [@Biotechnology] market capitalization is $11.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 6 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • NTLA’s TA Score: 6 bullish, 4 bearish.
  • TPST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than TPST.

Price Growth

NTLA (@Biotechnology) experienced а -3.34% price change this week, while TPST (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.38B) has a higher market cap than TPST($11.6M). NTLA YTD gains are higher at: 32.036 vs. TPST (-17.770). TPST has higher annual earnings (EBITDA): -35.35M vs. NTLA (-466.25M). NTLA has more cash in the bank: 511M vs. TPST (7.51M). TPST has less debt than NTLA: TPST (8.41M) vs NTLA (98M). NTLA has higher revenues than TPST: NTLA (57.5M) vs TPST (0).
NTLATPSTNTLA / TPST
Capitalization1.38B11.6M11,862%
EBITDA-466.25M-35.35M1,319%
Gain YTD32.036-17.770-180%
P/E RatioN/AN/A-
Revenue57.5M0-
Total Cash511M7.51M6,801%
Total Debt98M8.41M1,166%
FUNDAMENTALS RATINGS
NTLA vs TPST: Fundamental Ratings
NTLA
TPST
OUTLOOK RATING
1..100
7677
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4895
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (25) in the Biotechnology industry is in the same range as TPST (39) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew similarly to TPST’s over the last 12 months.

NTLA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew similarly to TPST’s over the last 12 months.

NTLA's SMR Rating (97) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew similarly to TPST’s over the last 12 months.

NTLA's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for TPST (95) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew somewhat faster than TPST’s over the last 12 months.

TPST's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as NTLA (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTLATPST
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NTLA
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAU3.020.29
+10.62%
Galiano Gold
PRQR1.460.07
+5.04%
ProQR Therapeutics NV
MIAX42.140.56
+1.35%
Miami International Holdings Inc
AMRZ58.830.44
+0.75%
AMRIZE AG
CENN0.13N/A
-0.47%
Cenntro

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+2.15%
CRSP - NTLA
74%
Closely correlated
+8.46%
VCYT - NTLA
69%
Closely correlated
+1.76%
ABCL - NTLA
69%
Closely correlated
+5.44%
CDXS - NTLA
66%
Closely correlated
+1.69%
TPST - NTLA
66%
Loosely correlated
+2.16%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with ARTV. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+2.16%
ARTV - TPST
89%
Closely correlated
+0.25%
VTGN - TPST
88%
Closely correlated
-7.23%
MREO - TPST
84%
Closely correlated
-4.32%
RZLT - TPST
83%
Closely correlated
+5.79%
LENZ - TPST
82%
Closely correlated
-0.69%
More